For those willing to wait and possibly switch later, Retatrutide may offer additional benefits when it becomes available
Cardiovascular diseases (CVDs) are the leading cause of mortality post-transplant, driven by prevalent traditional risk factors, along with complications related to chronic kidney disease (CKD), such as left ventricular hypertrophy and mineral bone disease, which often persist after the transplant [3, 4]
Its something to ask about before increasing your dose, especially if youve already noticed odd skin sensations on Wegovy
Consider as a possible cause for severe joint pain and discontinue drug if appropriate
Results guide your PlexusDx provider to recommend B12, folate, iron, and calcium dosing tailored to your genetic predispositions rather than generic guidelines